Global Marevan Market Growth 2025-2031

Publication ID:

LPI03259417

Publication Date:

March 31, 2025

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Marevan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Marevan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Marevan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Marevan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Marevan players cover Qilu Pharma, Sine Pharma (Shanghai Pharma), Henan Zhongjie Pharma, Amneal Pharma, TEVA (Barr, PLIVA), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢arevan Industry Forecast鈥� looks at past sales and reviews total world Marevan sales in 2024, providing a comprehensive analysis by region and market sector of projected Marevan sales for 2025 through 2031. With Marevan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marevan industry.
This Insight Report provides a comprehensive analysis of the global Marevan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marevan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Marevan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marevan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marevan.
This report presents a comprehensive overview, market shares, and growth opportunities of Marevan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
1mg/Tablet
2.5mg/Tablet
3mg/Tablet
5mg/Tablet
Others
Segmentation by Application:
Mechanical Heart Valves (MHV) Replacement
Atrial Fibrillation (AF)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Qilu Pharma
Sine Pharma (Shanghai Pharma)
Henan Zhongjie Pharma
Amneal Pharma
TEVA (Barr, PLIVA)
Cipla (InvaGen)
Orion Corporation Orion Pharma
Sawai Pharmaceutical
Zydus Pharmaceuticals
Taro Pharmaceutical Industries
IPCA LABS
Taj Pharma Group
Wuhan Shiji Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Marevan market?
What factors are driving Marevan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marevan market opportunities vary by end market size?
How does Marevan break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Marevan Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Marevan by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Marevan by Country/Region, 2020, 2024 & 2031
2.2 Marevan Segment by Type
2.2.1 1mg/Tablet
2.2.2 2.5mg/Tablet
2.2.3 3mg/Tablet
2.2.4 5mg/Tablet
2.2.5 Others
2.3 Marevan Sales by Type
2.3.1 Global Marevan Sales Market Share by Type (2020-2025)
2.3.2 Global Marevan Revenue and Market Share by Type (2020-2025)
2.3.3 Global Marevan Sale Price by Type (2020-2025)
2.4 Marevan Segment by Application
2.4.1 Mechanical Heart Valves (MHV) Replacement
2.4.2 Atrial Fibrillation (AF)
2.4.3 Deep Vein Thrombosis (DVT)
2.4.4 Pulmonary Embolism (PE)
2.4.5 Others
2.5 Marevan Sales by Application
2.5.1 Global Marevan Sale Market Share by Application (2020-2025)
2.5.2 Global Marevan Revenue and Market Share by Application (2020-2025)
2.5.3 Global Marevan Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Marevan Breakdown Data by Company
3.1.1 Global Marevan Annual Sales by Company (2020-2025)
3.1.2 Global Marevan Sales Market Share by Company (2020-2025)
3.2 Global Marevan Annual Revenue by Company (2020-2025)
3.2.1 Global Marevan Revenue by Company (2020-2025)
3.2.2 Global Marevan Revenue Market Share by Company (2020-2025)
3.3 Global Marevan Sale Price by Company
3.4 Key Manufacturers Marevan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Marevan Product Location Distribution
3.4.2 Players Marevan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Marevan by Geographic Region
4.1 World Historic Marevan Market Size by Geographic Region (2020-2025)
4.1.1 Global Marevan Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Marevan Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Marevan Market Size by Country/Region (2020-2025)
4.2.1 Global Marevan Annual Sales by Country/Region (2020-2025)
4.2.2 Global Marevan Annual Revenue by Country/Region (2020-2025)
4.3 Americas Marevan Sales Growth
4.4 APAC Marevan Sales Growth
4.5 Europe Marevan Sales Growth
4.6 Middle East & Africa Marevan Sales Growth
5 Americas
5.1 Americas Marevan Sales by Country
5.1.1 Americas Marevan Sales by Country (2020-2025)
5.1.2 Americas Marevan Revenue by Country (2020-2025)
5.2 Americas Marevan Sales by Type (2020-2025)
5.3 Americas Marevan Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Marevan Sales by Region
6.1.1 APAC Marevan Sales by Region (2020-2025)
6.1.2 APAC Marevan Revenue by Region (2020-2025)
6.2 APAC Marevan Sales by Type (2020-2025)
6.3 APAC Marevan Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Marevan by Country
7.1.1 Europe Marevan Sales by Country (2020-2025)
7.1.2 Europe Marevan Revenue by Country (2020-2025)
7.2 Europe Marevan Sales by Type (2020-2025)
7.3 Europe Marevan Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Marevan by Country
8.1.1 Middle East & Africa Marevan Sales by Country (2020-2025)
8.1.2 Middle East & Africa Marevan Revenue by Country (2020-2025)
8.2 Middle East & Africa Marevan Sales by Type (2020-2025)
8.3 Middle East & Africa Marevan Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Marevan
10.3 Manufacturing Process Analysis of Marevan
10.4 Industry Chain Structure of Marevan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Marevan Distributors
11.3 Marevan Customer
12 World Forecast Review for Marevan by Geographic Region
12.1 Global Marevan Market Size Forecast by Region
12.1.1 Global Marevan Forecast by Region (2026-2031)
12.1.2 Global Marevan Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Marevan Forecast by Type (2026-2031)
12.7 Global Marevan Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Qilu Pharma
13.1.1 Qilu Pharma Company Information
13.1.2 Qilu Pharma Marevan Product Portfolios and Specifications
13.1.3 Qilu Pharma Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Qilu Pharma Main Business Overview
13.1.5 Qilu Pharma Latest Developments
13.2 Sine Pharma (Shanghai Pharma)
13.2.1 Sine Pharma (Shanghai Pharma) Company Information
13.2.2 Sine Pharma (Shanghai Pharma) Marevan Product Portfolios and Specifications
13.2.3 Sine Pharma (Shanghai Pharma) Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sine Pharma (Shanghai Pharma) Main Business Overview
13.2.5 Sine Pharma (Shanghai Pharma) Latest Developments
13.3 Henan Zhongjie Pharma
13.3.1 Henan Zhongjie Pharma Company Information
13.3.2 Henan Zhongjie Pharma Marevan Product Portfolios and Specifications
13.3.3 Henan Zhongjie Pharma Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Henan Zhongjie Pharma Main Business Overview
13.3.5 Henan Zhongjie Pharma Latest Developments
13.4 Amneal Pharma
13.4.1 Amneal Pharma Company Information
13.4.2 Amneal Pharma Marevan Product Portfolios and Specifications
13.4.3 Amneal Pharma Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Amneal Pharma Main Business Overview
13.4.5 Amneal Pharma Latest Developments
13.5 TEVA (Barr, PLIVA)
13.5.1 TEVA (Barr, PLIVA) Company Information
13.5.2 TEVA (Barr, PLIVA) Marevan Product Portfolios and Specifications
13.5.3 TEVA (Barr, PLIVA) Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 TEVA (Barr, PLIVA) Main Business Overview
13.5.5 TEVA (Barr, PLIVA) Latest Developments
13.6 Cipla (InvaGen)
13.6.1 Cipla (InvaGen) Company Information
13.6.2 Cipla (InvaGen) Marevan Product Portfolios and Specifications
13.6.3 Cipla (InvaGen) Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cipla (InvaGen) Main Business Overview
13.6.5 Cipla (InvaGen) Latest Developments
13.7 Orion Corporation Orion Pharma
13.7.1 Orion Corporation Orion Pharma Company Information
13.7.2 Orion Corporation Orion Pharma Marevan Product Portfolios and Specifications
13.7.3 Orion Corporation Orion Pharma Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Orion Corporation Orion Pharma Main Business Overview
13.7.5 Orion Corporation Orion Pharma Latest Developments
13.8 Sawai Pharmaceutical
13.8.1 Sawai Pharmaceutical Company Information
13.8.2 Sawai Pharmaceutical Marevan Product Portfolios and Specifications
13.8.3 Sawai Pharmaceutical Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sawai Pharmaceutical Main Business Overview
13.8.5 Sawai Pharmaceutical Latest Developments
13.9 Zydus Pharmaceuticals
13.9.1 Zydus Pharmaceuticals Company Information
13.9.2 Zydus Pharmaceuticals Marevan Product Portfolios and Specifications
13.9.3 Zydus Pharmaceuticals Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zydus Pharmaceuticals Main Business Overview
13.9.5 Zydus Pharmaceuticals Latest Developments
13.10 Taro Pharmaceutical Industries
13.10.1 Taro Pharmaceutical Industries Company Information
13.10.2 Taro Pharmaceutical Industries Marevan Product Portfolios and Specifications
13.10.3 Taro Pharmaceutical Industries Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Taro Pharmaceutical Industries Main Business Overview
13.10.5 Taro Pharmaceutical Industries Latest Developments
13.11 IPCA LABS
13.11.1 IPCA LABS Company Information
13.11.2 IPCA LABS Marevan Product Portfolios and Specifications
13.11.3 IPCA LABS Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IPCA LABS Main Business Overview
13.11.5 IPCA LABS Latest Developments
13.12 Taj Pharma Group
13.12.1 Taj Pharma Group Company Information
13.12.2 Taj Pharma Group Marevan Product Portfolios and Specifications
13.12.3 Taj Pharma Group Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Taj Pharma Group Main Business Overview
13.12.5 Taj Pharma Group Latest Developments
13.13 Wuhan Shiji Pharmaceutical
13.13.1 Wuhan Shiji Pharmaceutical Company Information
13.13.2 Wuhan Shiji Pharmaceutical Marevan Product Portfolios and Specifications
13.13.3 Wuhan Shiji Pharmaceutical Marevan Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuhan Shiji Pharmaceutical Main Business Overview
13.13.5 Wuhan Shiji Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂